LONDON--(BUSINESS WIRE)--Dec. 1, 2016--
LivaNova PLC (NASDAQ:LIVN; LSE: LIVN) (“LivaNova” or the “Company”), a
market-leading medical technology and innovation company, today
announced that Vivid Sehgal, Chief Financial Officer of LivaNova, will
be presenting at the Berenberg European Conference in the United Kingdom
on Wednesday, December 7, 2016 at 9:45 a.m.
About LivaNova
LivaNova PLC is a global medical technology company formed by the merger
of Sorin S.p.A, a leader in the treatment of cardiovascular diseases,
and Cyberonics Inc., a medical device company with core expertise in
neuromodulation. LivaNova transforms medical innovation into meaningful
solutions for the benefit of patients, healthcare professionals, and
healthcare systems.
The Company employs approximately 4,600 employees worldwide and is
headquartered in London, U.K.
For more information, please visit www.livanova.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161201006340/en/
Source: LivaNova PLC
LivaNova PLC
Investor Relations and Media
Karen
King, +1 (281) 228-7262
Vice President, Investor Relations &
Corporate Communications
Fax: +1 (281) 218-9332
corporate.communications@livanova.com